Gilead Sciences, Inc. - Momentum - Zacks Rank Buy

1Z1-9732_29_84

Publication: Zacks Investment Research - Momentum - Zacks Rank Buy

Date: 2009-01-13 00:00:00

Gilead Sciences, Inc. - Momentum - Zacks Rank Buy

Gilead Sciences, Inc.'s ( GILD ) share price continues to head north in response to higher estimates related to the strength of the company's HIV drug franchise.

Company Description

Gilead Sciences, Inc. is a biopharmaceutical company that develops therapeutics for treating life threatening infectious diseases. The company is listed in a number of indexes, including the S&P 500 and has a market cap of $43 billion.

To read the rest of the article, click here to take a free trial!